SE7603791L - Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner - Google Patents

Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner

Info

Publication number
SE7603791L
SE7603791L SE7603791A SE7603791A SE7603791L SE 7603791 L SE7603791 L SE 7603791L SE 7603791 A SE7603791 A SE 7603791A SE 7603791 A SE7603791 A SE 7603791A SE 7603791 L SE7603791 L SE 7603791L
Authority
SE
Sweden
Prior art keywords
pregnants
alfa
halogen
ester
procedure
Prior art date
Application number
SE7603791A
Other languages
English (en)
Other versions
SE403380B (sv
Inventor
Y Kamano
K Michishita
T Seki
I Tanaka
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50038914A external-priority patent/JPS51125372A/ja
Priority claimed from JP50052085A external-priority patent/JPS51128954A/ja
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of SE7603791L publication Critical patent/SE7603791L/sv
Publication of SE403380B publication Critical patent/SE403380B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
SE7603791A 1975-03-31 1976-03-30 Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner SE403380B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50038914A JPS51125372A (en) 1975-03-31 1975-03-31 Aprocess for preparing pregnane steroid-17-ester-21-halides
JP50052085A JPS51128954A (en) 1975-05-01 1975-05-01 Process for preparing 17-ester-21-halides of pregnate type s teroids

Publications (2)

Publication Number Publication Date
SE7603791L true SE7603791L (sv) 1976-10-01
SE403380B SE403380B (sv) 1978-08-14

Family

ID=26378215

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603791A SE403380B (sv) 1975-03-31 1976-03-30 Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner

Country Status (14)

Country Link
US (1) US4113680A (sv)
CA (1) CA1044225A (sv)
CH (1) CH609709A5 (sv)
DE (1) DE2613875A1 (sv)
DK (1) DK141171B (sv)
ES (1) ES446411A1 (sv)
FR (1) FR2306214A1 (sv)
GB (1) GB1508517A (sv)
HU (1) HU174850B (sv)
IN (1) IN142583B (sv)
NL (1) NL7603249A (sv)
PT (1) PT64885B (sv)
SE (1) SE403380B (sv)
YU (1) YU54476A (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2742982C2 (de) * 1977-09-21 1985-12-12 Schering AG, 1000 Berlin und 4709 Bergkamen 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4361558A (en) * 1980-04-29 1982-11-30 Ciba-Geigy Corporation Halogenated steroids
US4440689A (en) * 1981-07-22 1984-04-03 Mitsubishi Chemical Industries, Limited Acyloxysteroids and process for producing same
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
DE3915951C1 (sv) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
ES2523930T3 (es) * 2000-08-05 2014-12-02 Glaxo Group Limited Éster s-fluorometílico del ácido 6-alfa,9-alfa-difluoro-17-alfa-[(2-furanilcarbonil)oxi]-11-beta-hidroxi-16-alfa-metil-3-oxo-androst-1,4-dien-17-carbotioico como agente antiinflamatorio
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
DE60229372D1 (de) * 2001-04-30 2008-11-27 Glaxo Group Ltd Antiphlogistische 7.beta.-carbothioate esterderivate von androstan mit einer 17.alpha.-zyklischen estergruppe
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
AT501376B1 (de) * 2005-01-17 2010-11-15 Pregenzer Bruno Glucokortikoid-hältiges arzneimittel
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN109608511B (zh) * 2019-01-24 2021-05-04 上海新华联制药有限公司 泼尼松龙醋酸戊酸酯的化学合成工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE373332C (sv) * 1972-02-25 1977-07-14 Centralsug Ab Anordning for utvinning av fibermaterial ur blandat gods
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
DK141171C (sv) 1980-07-07
HU174850B (hu) 1980-03-28
DK144076A (sv) 1976-10-01
ES446411A1 (es) 1979-02-01
IN142583B (sv) 1977-07-30
CH609709A5 (sv) 1979-03-15
FR2306214A1 (fr) 1976-10-29
PT64885B (en) 1977-11-17
CA1044225A (en) 1978-12-12
PT64885A (en) 1976-04-01
NL7603249A (nl) 1976-10-04
SE403380B (sv) 1978-08-14
GB1508517A (en) 1978-04-26
US4113680A (en) 1978-09-12
FR2306214B1 (sv) 1981-04-30
YU54476A (en) 1982-05-31
DK141171B (da) 1980-01-28
DE2613875A1 (de) 1976-10-14

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
SE7603791L (sv) Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
SE433610B (sv) Forfarande for framstellning av aromatiska uretaner
SE427031B (sv) Forfarande for framstellning av (d-trp?726)-lh-rh
SE7604475L (sv) Forfarande for framstellning av 1,1,1-triaryl-alkylaminer
SE7611280L (sv) Forfarande for framstellning av 3-hydroxi-3-cefemestersulfoxider
SE7607717L (sv) Analogiforfarande for framstellning av l-pyroglutamyl-l-prolinamid
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE428922B (sv) Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner
SE7601605L (sv) Forfarande for framstellning av 1 alfa,25-dihydroxi-cholkalciferol
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
NO142444C (no) Fremgangsmaate for fremstilling av foretrede melamin-formaldehydharpikser i vandig opploesning
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE7608453L (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7605427L (sv) Forfarande for framstellning av klorcyan
SE7603682L (sv) Forfarande for framstellning av en eteriskt substituerad monosackarid